Cargando…

A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus

INTRODUCTION: Previous research has demonstrated a correlation among patient preferences, dosing burden, and medication nonadherence, a well-recognized challenge in type 2 diabetes mellitus (T2DM). The objective of this study was to elicit preferences for alternative dosing regimens for oral antihyp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hauber, A. Brett, Tunceli, Kaan, Yang, Jui-Chen, Gantz, Ira, Brodovicz, Kimberly G., Alexander, Charles M., Davies, Michael J., Radican, Larry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374080/ https://www.ncbi.nlm.nih.gov/pubmed/25586555 http://dx.doi.org/10.1007/s13300-015-0094-2

Ejemplares similares

Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes
por: Tunceli, Kaan, et al.
Publicado: (2015)

Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes
por: Hauber, A Brett, et al.
Publicado: (2013)

Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey study
por: Marrett, Elizabeth, et al.
Publicado: (2011)

Multinational Internet-based survey of patient preference for newer oral or injectable Type 2 diabetes medication
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2010)

Use of Add-on Treatment to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A U.S. Database Study
por: Yu, Shengsheng, et al.
Publicado: (2016)

Adherence to dipeptidyl peptidase‐4 inhibitor therapy among type 2 diabetes patients with employer‐sponsored health insurance in Japan
por: Kurtyka, Karen, et al.
Publicado: (2016)

Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy
por: Inzucchi, S. E., et al.
Publicado: (2015)

Reasons given by general practitioners for non-treatment decisions in younger and older patients with newly diagnosed type 2 diabetes mellitus in the United Kingdom: a survey study
por: Zhang, Qiaoyi, et al.
Publicado: (2011)

Physician Reasons for Nonpharmacologic Treatment of Hyperglycemia in Older Patients Newly Diagnosed with Type 2 Diabetes Mellitus
por: Marrett, Elizabeth, et al.
Publicado: (2012)

A Randomized, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Adding Omarigliptin to Antihyperglycemic Therapies in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control
por: Gantz, Ira, et al.
Publicado: (2017)

One-year adherence to oral antihyperglycemic medication and risk prediction of patient outcomes for adults with diabetes mellitus: An observational study
por: Huber, Carola A., et al.
Publicado: (2016)

Glycemic Control in Chinese Patients with Type 2 Diabetes Mellitus Receiving Oral Antihyperglycemic Medication-Only or Insulin-Only Treatment: A Cross-Sectional Survey
por: Chen, Yun, et al.
Publicado: (2015)

Hemodialysis patients’ preferences for the management of anemia
por: Hauber, Brett, et al.
Publicado: (2017)

Dyslipidemia: The untreated metabolic dysfunction in people with type 2 diabetes in Latin America. ARETAEUS study outcomes
por: José Gagliardino, Juan, et al.
Publicado: (2019)

Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism
por: Hauber, Brett, et al.
Publicado: (2017)

Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study
por: Fu, Alex Z, et al.
Publicado: (2010)

Exploring Decisional Conflict With Measures of Numeracy and Optimism in a Stated Preference Survey
por: Sutphin, Jessie, et al.
Publicado: (2021)

Patient preferences for gene therapy in haemophilia: Results from the PAVING threshold technique survey
por: van Overbeeke, Eline, et al.
Publicado: (2021)

Incretin-Based Antihyperglycemic Agents for the Management of Acute Ischemic Stroke in Patients with Diabetes Mellitus: A Review
por: Milonas, Dimitrios, et al.
Publicado: (2019)

Antihyperglycemic effect of thymoquinone and oleuropein, on streptozotocin-induced diabetes mellitus in experimental animals
por: Sangi, Sibghatullah Muhammad Ali, et al.
Publicado: (2015)

Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus
por: Zhu, Wei, et al.
Publicado: (2019)

Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review
por: Farsani, Soulmaz Fazeli, et al.
Publicado: (2017)

Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat
por: Davis, Kimberly H., et al.
Publicado: (2017)

Efficacy and safety of ertugliflozin in East/Southeast Asian patients with type 2 diabetes mellitus
por: Liu, Jie, et al.
Publicado: (2020)

The Value of Hope: Patients’ and Physicians’ Preferences for Survival in Advanced Non-Small Cell Lung Cancer
por: Hauber, Brett, et al.
Publicado: (2020)

Communicating Test Results from a General Health Check: Preferences from a Discrete Choice Experiment Survey
por: Grauman, Åsa, et al.
Publicado: (2021)

Patient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST)
por: Hauber, A Brett, et al.
Publicado: (2011)

Assessment of dog owner adherence to veterinarians’ flea and tick prevention recommendations in the United States using a cross-sectional survey
por: Lavan, Robert P., et al.
Publicado: (2017)

Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase– lowering effects of garlic in patients with type 2 diabetes mellitus with obesity
por: Kumar, Rahat, et al.
Publicado: (2013)

What Is Valued Most by Patients With Type 2 Diabetes Mellitus When Selecting Second-Line Antihyperglycemic Medications in China
por: Liu, Shimeng, et al.
Publicado: (2021)

Nonadherence of Oral Antihyperglycemic Medication Will Increase Risk of End-Stage Renal Disease
por: Chang, Po-Ya, et al.
Publicado: (2015)

Cohort Study of Antihyperglycemic Medication and Pancreatic Cancer Patients Survival
por: Dulskas, Audrius, et al.
Publicado: (2020)

Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia
por: Graham-Clarke, Peita L, et al.
Publicado: (2020)

Patient Preferences to Assess Value IN Gene Therapies: Protocol Development for the PAVING Study in Hemophilia
por: van Overbeeke, Eline, et al.
Publicado: (2021)

Patient and physician preferences for ulcerative colitis treatments in the United States
por: Boeri, Marco, et al.
Publicado: (2019)

Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision Analysis
por: Broekhuizen, Henk, et al.
Publicado: (2016)

Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
por: Ko, Seung-Hyun, et al.
Publicado: (2017)

Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
por: Ko, Seung-Hyun, et al.
Publicado: (2017)

Antihyperglycemic Medications and Cardiovascular Risk Reduction
por: Anderson, Sarah L, et al.
Publicado: (2017)

Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetes
por: Guzauskas, Gregory F, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_23v9qlhj7lccpj0cfkhb5pq178